Pathogenesis ofAspergillus fumigatusand the Kinetics of Galactomannan in an In Vitro Model of Early Invasive Pulmonary Aspergillosis: Implications for Antifungal Therapy
Author(s) -
William Hope,
Michael J. Kruhlak,
Caron A. Lyman,
Rūta Petraitienė,
Vidmantas Petraitis,
Andrea Francesconi,
Miki Kasai,
Diana Mickiene,
Tin Sein,
Joanne Peter,
Amy M. Kelaher,
Johanna E. Hughes,
Margaret P. Cotton,
Catherine J. Cotten,
John Bacher,
Sanjay Tripathi,
Louis Bermudez,
Timothy K. Maugel,
Patricia M. Zerfas,
John R. Wingard,
George L. Drusano,
Thomas J. Walsh
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/510535
Subject(s) - aspergillus fumigatus , galactomannan , amphotericin b , aspergillosis , antifungal drug , pathogenesis , microbiology and biotechnology , biology , immunology , antifungal
Little is known about the pathogenesis of invasive pulmonary aspergillosis and the relationship between the kinetics of diagnostic markers and the outcome of antifungal therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom